Disciplined Investments, LLC Dexcom Inc Transaction History

Disciplined Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$112.47 - $130.98 $224 - $261	-2 Reduced 22.22%	7 $0
Q4 2022 Feb 01, 2023	BUY	$84.98 - $122.67 $84 - $122	1 Added 12.5%	9 $1,000
Q3 2022 Nov 03, 2022	BUY	$76.35 - $94.18 $76 - $94	1 Added 14.29%	8 $1,000
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $203 - $398	3 Added 75.0%	7 $1,000
Q1 2022 Apr 22, 2022	BUY	$94.08 - $130.2 $376 - $520	4 New	4 $2,000
Q1 2020 May 19, 2020	SELL	$47.79 - $75.63 $238 - $378	-5 Closed	0 $0
Q4 2019 May 19, 2020	BUY	$36.62 - $57.29 $183 - $286	5 New	5 $1,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.